US equities |
MU $878.84 ▼-5.63% NVDA $214.13 ▼-1.43% TSLA $354.72 ▼-2.13% AAPL $343.46 ▲+0.43% META $709.33 ▼-3.72% MSFT $529.05 ▼-1.93% SPCX $146.03 ▼-1.74% AMD $528.75 ▼-5.95%
FinancialContent

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

3.920 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
From Vyome Therapeutics, Inc. and ReShape Lifesciences Inc.
Via Business Wire
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
These stocks have an unusual volume in today's session ↗
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. 
Via Chartmill
ReShape Lifesciences Stock Rocketed 37% Today – Here’s Why ↗
Via Stocktwits
News headline image
Here are the top movers in Wednesday's session. ↗
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Top movers in Wednesday's session ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
From ReShape Lifesciences
Via Business Wire
News headline image
Vyome Announces New Board of Directors with Deep MIT and AI Ties
From Vyome Therapeutics and ReShape Lifesciences
Via Business Wire
News headline image
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
From ReShape Lifesciences
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Thursday's after hours session: top gainers and losers ↗
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
News headline image
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System
Patent Enhances and Broadens the Company’s Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric Device 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
ReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology
Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Here are the top movers in Thursday's session. ↗
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
AI & Tech Breakout: PRSO, IPA, NEHC, SOAR Lead Today’s Innovation Surge – More Movers Inside
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause ↗
Under the distribution agreement, Recon Supply will distribute ReShape’s portfolio across the Veterans Administration and Department of Defense healthcare systems. 
Via Stocktwits
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
Recon Supply Named Exclusive U.S. Distributor of ReShape’s STIMEL-03, Lap-Band® 2.0 FLEX, and Full Product Portfolio to Reach U.S. Veterans and Active-Duty Service Members 
From ReShape Lifesciences Inc
Via GlobeNewswire
News headline image
Which stocks are moving on Monday? ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
ReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To Optimism ↗
The offer price of $2.50 represents a 40% discount to the stock’s closing price of $4.18 on Friday. 
Via Stocktwits
News headline image
Crude Oil Moves Higher; Graham Shares Surge After Q4 Results ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >